Trial
NCT03296696
Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Amgen
Collaborators
—
Condition
Glioblastoma or Malignant Glioma
Intervention
AMG 596
Why stopped
Amgen business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-29